Lumbosacral Plexus Neurolymphomatosis A Typical 18FDG PET/CT Pattern to Recognize

被引：2

作者：

Bordeau, Karl ^{[1
]}

Eberle, Marie-Claude ^{[1
]}

Fabbro, Michel ^{[2
]}

Fersing, Cyril ^{[1
,3
]}

Deshayes, Emmanuel ^{[1
,4
]}

机构：

[1] Univ Montpellier, Inst Reg Canc Montpellier, Dept Nucl Med, 208 Ave Apothicaires, F-34298 Montpellier 05, France

[2] Univ Montpellier, Inst Reg Canc Montpellier, Dept Med Oncol, Montpellier, France

[3] Univ Montpellier, Inst Biomol Max Mousseron, CNRS, UMR5247,ENSCM,UFR Sci Pharmaceut & Biol, Montpellier, France

[4] Univ Montpellier, Inst Reg Canc Montpellier, Inst Rech Cancerol Montpellier, INSERM,U1194, Montpellier, France

来源：

CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 04期

关键词：

(18)FDG PET/CT; neurolymphomatosis; primary CNS lymphoma; lumbosacral plexus; DIAGNOSIS;

D O I：

10.1097/RLU.0000000000003949

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 79-year-old man anteriorly treated for primary central nervous system diffuse large B-cell lymphoma with MRI complete response after immunochemotherapy was referred 1 year later for 18FDG PET/CT because of right persistent lombosciatic radicular pain for 6 months with negative medullary and spine MRI and negative cerebrospinal fluid cytology. Linearly intense uptake was observed in several roots of lumbosacral plexus, highly suggestive of peripheral neurolymphomatosis relapse. No specific treatment was engaged because of rapid decrease of performance status leading to death. © Wolters Kluwer Health, Inc. All rights reserved.

引用

页码：352 / 353

页数：2

共 50 条

[1] Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment)
Kobylecka, Malgorzata
Maczewska, Joanna
Fronczewska-Wieniawska, Katarzyna
Mazurek, Tomasz
Plazinska, Maria Teresa
Krolicki, Leszek
NUCLEAR MEDICINE REVIEW, 2012, 15 (01) : 52 - 60
[2] FDG PET/CT in Neurolymphomatosis
Soni, Neetu
Ora, Manish
RADIOLOGY, 2021, 298 (01) : 36 - 36
[3] Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT
Rasheed, Rashid
Al-Kandari, Fareeda
Rizvi, Syed Faheem Askari
Usmani, Sharjeel
IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2020, 28 (01): : 54 - 56
[4] Neurolymphomatosis diagnosed on [18F]FDG PET/CT
Benameur, Yassir
Sahel, Omar Ait
Oueriagli, Salah Nabih
Doudouh, Abderrahim
NUCLEAR MEDICINE REVIEW, 2023, 26 : 96 - 97
[5] Role of 18FDG PET/CT in Breast Cancer
Fatima, Nosheen
Zaman, Maseeh Uz
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (03): : 177 - 179
[6] Typical and Atypical 18FDG PET/CT Findings in Two Cases of Cat Scratch Disease
Zhou, Wei
Gong, Lianggeng
Zuo, Changjing
Zhang, Jian
CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E388 - E391
[7] 18FDG PET/CT Imaging in Carcinoma Oesophagus
Zaman, Maseeh Uz
Fatima, Nosheen
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (04): : 417 - 418
[8] Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging
Cook, GJR
Wegner, EA
Fogelman, I
SEMINARS IN NUCLEAR MEDICINE, 2004, 34 (02) : 122 - 133
[9] FDG PET/CT in Pediatric Neurolymphomatosis
de Vaugelade, Carole
de Clermont-Gallerande, Henri
Meyer, Marie
Tiphaine, Aude My Duyen
Benjamin, Alice
Ducassou, Stephane
Chateil, Jean-Francois
Fernandez, Philippe
CLINICAL NUCLEAR MEDICINE, 2017, 42 (05) : E255 - E257
[10] Neurolymphomatosis Diagnosed by 18F-FDG PET-CT
Salm, Liesbeth P.
Van der Hiel, Bernies
Stokkel, Marcel P. M.
CLINICAL NUCLEAR MEDICINE, 2013, 38 (06) : E261 - E262

← 1 2 3 4 5 →